PACS Group (NYSE:PACS) Given New $46.00 Price Target at Truist Financial

PACS Group (NYSE:PACSFree Report) had its price objective increased by Truist Financial from $44.00 to $46.00 in a research report report published on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock.

A number of other research firms have also weighed in on PACS. UBS Group assumed coverage on shares of PACS Group in a research note on Wednesday, October 9th. They issued a buy rating and a $50.00 price objective on the stock. Citigroup assumed coverage on shares of PACS Group in a research report on Wednesday, September 11th. They set a buy rating and a $45.00 price target on the stock. Oppenheimer raised their price target on shares of PACS Group from $32.00 to $40.00 and gave the company an outperform rating in a research report on Tuesday, August 13th. Stephens raised their price target on shares of PACS Group from $37.00 to $40.00 and gave the company an overweight rating in a research report on Tuesday, August 13th. Finally, Macquarie assumed coverage on shares of PACS Group in a research report on Friday, June 28th. They set an outperform rating and a $35.00 price target on the stock. Eight analysts have rated the stock with a buy rating, According to MarketBeat.com, PACS Group currently has a consensus rating of Buy and an average price target of $39.38.

Read Our Latest Analysis on PACS Group

PACS Group Price Performance

Shares of NYSE PACS opened at $40.11 on Monday. PACS Group has a 12-month low of $22.61 and a 12-month high of $42.25. The business’s fifty day moving average is $38.82. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.71 and a current ratio of 1.71.

PACS Group (NYSE:PACSGet Free Report) last released its quarterly earnings data on Monday, August 12th. The company reported ($0.07) earnings per share for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.42). The business had revenue of $981.80 million for the quarter, compared to analysts’ expectations of $919.22 million. The business’s revenue for the quarter was up 29.1% compared to the same quarter last year. As a group, sell-side analysts forecast that PACS Group will post 1.03 EPS for the current fiscal year.

Institutional Trading of PACS Group

Large investors have recently added to or reduced their stakes in the stock. Caas Capital Management LP purchased a new position in shares of PACS Group in the second quarter worth about $1,386,000. Bank of New York Mellon Corp purchased a new position in shares of PACS Group in the second quarter worth about $2,445,000. Allspring Global Investments Holdings LLC purchased a new position in PACS Group during the second quarter valued at approximately $7,513,000. Rhumbline Advisers purchased a new position in PACS Group during the second quarter valued at approximately $870,000. Finally, Oppenheimer Asset Management Inc. purchased a new position in PACS Group during the second quarter valued at approximately $552,000.

About PACS Group

(Get Free Report)

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.

Further Reading

Analyst Recommendations for PACS Group (NYSE:PACS)

Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.